CLINICAL_TRIALS
trial_result
· 2019-06-06
Clinical Trial Update: Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris [Phase 3]
Summary
Phase 3 trial of ofatumumab for pemphigus vulgaris was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Pemphigus Vulgaris | Phase 3 | Status: TERMINATED | Results posted: 2019-06-06